Why Roivant Sciences Ltd. (ROIV) Surged On Thursday

We recently published a list of While Wall Street Naps, These 10 Stocks Run Wild. In this article, we are going to take a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) stands against other best-performing stocks.

Roivant Sciences ended a three-day losing streak on Thursday, jumping 6.4 percent to finish at $11.30 each, as investors resorted to bargain-hunting, shunning its dismal earnings performance in the past quarter of the year.

On the same day, Roivant Sciences Ltd. (NASDAQ:ROIV) widened its attributable net loss by 36 percent to $206 million in the fourth quarter of fiscal year 2025, from $151 million in the same period last year. Revenues dropped by 16 percent to $7.57 billion from $9.02 billion year-on-year.

WhyRoivant Sciences Ltd. (ROIV) Surged On Thursday

A research scientist in a lab coat examining a sample of blood for sickle cell diseases.

For the full fiscal year period, Roivant Sciences Ltd. (NASDAQ:ROIV) swung to an attributable net loss of $171.98 million from a $ 4.35 billion attributable net income a year earlier.

Revenues, on the other hand, dropped by 11 percent to $29 billion from $32.7 billion year-on-year.

Overall, ROIV ranks 4th on our list of best-performing stocks. While we acknowledge the potential of ROIV, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ROIV and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.